Scitech pharma
Scitech pharma develops small-molecule therapeutics for oncology, autoimmune and central nervous system disorders using AI to speed discovery and optimize clinical value. The company applies AI-driven computational chemistry and high-throughput in-silico screening to design and prioritize compounds, combined with medicinal chemistry and preclinical workflows. It operates as a biopharma drug developer focused on translating AI-generated candidates into lead optimization and IND-enabling studies. Scitech targets therapeutic areas with high unmet need and aims to advance programs toward clinical development.
Scitech pharma
Scitech pharma develops small-molecule therapeutics for oncology, autoimmune and central nervous system disorders using AI to speed discovery and optimize clinical value. The company applies AI-driven computational chemistry and high-throughput in-silico screening to design and prioritize compounds, combined with medicinal chemistry and preclinical workflows. It operates as a biopharma drug developer focused on translating AI-generated candidates into lead optimization and IND-enabling studies. Scitech targets therapeutic areas with high unmet need and aims to advance programs toward clinical development.